Shanghai Aohua Photoelectricity Endoscope Future Growth
Future criteria checks 5/6
Shanghai Aohua Photoelectricity Endoscope is forecast to grow earnings and revenue by 59.8% and 22.9% per annum respectively. EPS is expected to grow by 59.8% per annum. Return on equity is forecast to be 11.7% in 3 years.
Key information
59.8%
Earnings growth rate
59.8%
EPS growth rate
| Medical Equipment earnings growth | 26.7% |
| Revenue growth rate | 22.9% |
| Future return on equity | 11.7% |
| Analyst coverage | Good |
| Last updated | 22 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,501 | 223 | 64 | 158 | 7 |
| 12/31/2025 | 1,132 | 135 | 5 | 91 | 7 |
| 12/31/2024 | 866 | 81 | -108 | 88 | 7 |
| 9/30/2024 | 750 | 50 | -231 | -64 | N/A |
| 6/30/2024 | 743 | 25 | -226 | -62 | N/A |
| 3/31/2024 | 722 | 44 | -200 | -36 | N/A |
| 12/31/2023 | 678 | 58 | -120 | 37 | N/A |
| 9/30/2023 | 593 | 58 | -186 | -15 | N/A |
| 6/30/2023 | 567 | 55 | -185 | -36 | N/A |
| 3/31/2023 | 489 | 35 | -126 | -42 | N/A |
| 12/31/2022 | 445 | 22 | -121 | -42 | N/A |
| 9/30/2022 | 399 | 45 | -133 | -28 | N/A |
| 6/30/2022 | 368 | 53 | -86 | 5 | N/A |
| 3/31/2022 | 357 | 51 | -86 | 9 | N/A |
| 12/31/2021 | 347 | 57 | -25 | 66 | N/A |
| 9/30/2021 | 341 | 67 | 61 | 101 | N/A |
| 6/30/2021 | 317 | 45 | 49 | 89 | N/A |
| 3/31/2021 | 288 | 37 | 43 | 94 | N/A |
| 12/31/2020 | 263 | 19 | 10 | 72 | N/A |
| 12/31/2019 | 298 | 53 | -18 | 47 | N/A |
| 12/31/2018 | 156 | -6 | -80 | -18 | N/A |
| 12/31/2017 | 130 | -4 | N/A | -26 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688212's forecast earnings growth (59.8% per year) is above the savings rate (2.8%).
Earnings vs Market: 688212's earnings (59.8% per year) are forecast to grow faster than the CN market (26.2% per year).
High Growth Earnings: 688212's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688212's revenue (22.9% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 688212's revenue (22.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688212's Return on Equity is forecast to be low in 3 years time (11.7%).